| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/25/2008 | US20080234212 siRNA molecules which target the transcription factor STAT6 and repress the expression of STAT6 mRNA, STAT6 protein and STAT6 function in lung cells |
| 09/25/2008 | US20080234211 Decladinosyl-Macrolides With Anti-Inflammatory Activity |
| 09/25/2008 | US20080234209 Derivatives of N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamide; for preparation of drugs, gastrointestinal tract disease |
| 09/25/2008 | US20080234208 Angina pectoris, myocardial ischemia, hemorrhagic shock, heart failure, and arrhythmia; ginsenoside with protopanoxadiol as aglucone (ginsenoside Rg3) and the ginsenoside with protopanoxatriol as aglucone (ginsenoside Rg2 and ginsenoside Rh1) |
| 09/25/2008 | US20080234207 Antidiabetic agent, blood glucose control abnormality; ginsenosides Rg3, Rg5, and Rk1 from natural substances |
| 09/25/2008 | US20080234206 Prodrugs of Phentermine |
| 09/25/2008 | US20080234204 Methods for evaluating and implementing prostate disease treatments |
| 09/25/2008 | US20080234199 Chemical Compounds |
| 09/25/2008 | US20080234195 Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations |
| 09/25/2008 | US20080234187 In particular amidated, acetylated, phosphorylated and/or glycosylated derivatives; diagnostic agents including a nucleic acid or messenger RNA coding for the cytokine; isolated from human hemofiltrate |
| 09/25/2008 | US20080234183 Predicting or designing, detecting, and/or verifying a novel cell-penetrating peptide that mimics cellular effector activity; vectors; treating and/or preventing infectious diseases, diabetes type I and II, Alzheimer's Disease, Parkinson's Disease, and cancer. |
| 09/25/2008 | US20080234182 Compound having a symmetry and size capable of fitting to an opening of the pore of a pore-forming pathogen for binding such that upon binding, the pore or prepore is blocked, especially cyclodextrin derivatives; combatting biological warfare; drug screening; drug design |
| 09/25/2008 | US20080233651 Method and medicament for inhibiting the expression of a given gene |
| 09/25/2008 | US20080233595 Method for diagnosing intertility |
| 09/25/2008 | US20080233222 Method of Improving Cardiovascular Health |
| 09/25/2008 | US20080233220 Use of botanical ingredients from a species of each of the genera Silybum, Astragalus or Hedysarum, Salvia, and Schisandra for treatment of liver inflammation associated with hepatitis B virus, alcohol abuse, metabolic disorders associated with the liver, or chemotherapy side effects |
| 09/25/2008 | US20080233215 Excipient and an improved method for manufacturing extracted, evaporated, granulated botanical herb product |
| 09/25/2008 | US20080233214 Demonstrate cytotoxic activity against a variety of cell types exhibiting hyperproliferative cell division; anticarcinogenic agents; ovarian cancer; naphtho(2,3-b)furan derivatives |
| 09/25/2008 | US20080233211 Aqueous composition of sodium selenite and hydrocortisone; sepsis, Systemic Inflammatory Response Sydndrome, and/or septic shock |
| 09/25/2008 | US20080233209 Composition and method of use for the treatment of metabolic syndrome and inflammation |
| 09/25/2008 | US20080233208 Administering a composition of a 3,4,5-trimethoxyl phenyl ethyl-2-methoxy-phenol; enhancing the efficacy of chemotherapeutics without adding to its toxicity |
| 09/25/2008 | US20080233206 Compositions and methods for anti-inflammatory treatments |
| 09/25/2008 | US20080233201 Method for Preparing Calibrated Biodegradable Microspheres |
| 09/25/2008 | US20080233196 With sterile sodium bicarbonate, soluble in water, high stability with time. |
| 09/25/2008 | US20080233195 Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth |
| 09/25/2008 | US20080233194 Stabilized ; dispersion in dispersion microstructure; administering to lungs |
| 09/25/2008 | US20080233193 Oral antimicrobial pharmaceutical compositions |
| 09/25/2008 | US20080233191 Use of ranolazine for elevated brain-type natriuretic peptide |
| 09/25/2008 | US20080233189 Contiguous with compositionally substantially identical unitary segments that contain drugs; accurate means of dosing with a compressed, segmented pharmaceutical tablet |
| 09/25/2008 | US20080233188 [5-(4-bromo-phenyl)-6-[2-(5-bromo-pyrimidin-2-yloxy)-ethoxy]-pyrimidin-4-yl]-amide, a disintegrant, a surfactant, and a lubricant; endothelin receptor inhibitor |
| 09/25/2008 | US20080233187 Method of Production of Fine-Crystalline Mixture Containing Non-Steroid Anti-Inflammatory Drug, Fine-Crystalline Mixture Obtainable by this Method and Solid Pharmaceutical Composition Containing this Mixture |
| 09/25/2008 | US20080233186 Dietary composition of L-Arginine alpha amino n-Butryate; enhancing lean body mass and exercise performance |
| 09/25/2008 | US20080233185 Using dimethyl fumarate and/or diethyl fumarate, calcium alkyl fumarate, calcium methyl fumarate and/or calcium ethyl fumarate, zinc methyl fumarate and/or zinc ethyl fumarate, methyl hydrogen fumarate and/or ethyl hydrogen fumarate; sclerodermia, osteochondritis syphilitica (Wegener's disease) |
| 09/25/2008 | US20080233183 Liposomal concentrate of a phospholipid, lipophilic bioactive agent, a solubilizer, a carrier permeation enhancer; analgesics, anti-inflammatory agents, anthelmintics, anti-arrhythmic agents, anti-bacterial agents, anti-viral agents, anti-coagulants, anti-depressants, anti-diabetics |
| 09/25/2008 | US20080233182 Organic compounds |
| 09/25/2008 | US20080233180 Transdermal Patch and Method For Delivery Of Vitamin B12 |
| 09/25/2008 | US20080233179 Transdermal composition having enhanced color stability |
| 09/25/2008 | US20080233178 Opioid antagonist dispersed in a polymeric matrix; releasing opioid antagonist if the transdermal delivery device is chewed, soaked, punctured, torn, or subjected to any other treatment which disrupts the integrity of the microspheres |
| 09/25/2008 | US20080233177 Applying individually dosed portions of a flowable, active substance-containing preparation onto a pressure-sensitive adhesive laye, applying an impermeable, backing layer; cutting and punching from the composite laminate |
| 09/25/2008 | US20080233176 Haemostatic composition and method |
| 09/25/2008 | US20080233173 Inserting an implant into an ocular site; an active agent and a polymer carrier; releasing the active agent from the implant |
| 09/25/2008 | US20080233172 Inserting an implant into an ocular site; an active agent and a polymer carrier; releasing the active agent from the implant |
| 09/25/2008 | US20080233171 Inserting an implant into an ocular site; an active agent and a polymer carrier; releasing the active agent from the implant |
| 09/25/2008 | US20080233168 Medical Devices And Coatings Therefore Comprising Biodegradable Polymers With Enhanced Functionality |
| 09/25/2008 | US20080233163 4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenylamine; N-{4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenyl}-acetamide; or4-Methyl-5-(2-nitrooxy-ethyl)-2-(4-nitro-phenyl)-thiazole; cardiovascular, gastrointestinal, inflammatory, respiratory disease |
| 09/25/2008 | US20080233158 Two-coat makeup product, its uses, and makeup kit comprising the product |
| 09/25/2008 | US20080233157 Inhibiting surface enhanced crystallization of amorphous pharmaceuticals with ultrathin coatings |
| 09/25/2008 | US20080233156 Pharmaceutical compositions |
| 09/25/2008 | US20080233151 Calmodulin and metalloproteinase exotoxins; vaccine; anthrax |
| 09/25/2008 | US20080233145 Pharmaceutical Compositions Comprising Old Man's Beard (Usnea Barbata) and St. John's Wort (Hypericum Perforatum) and Their Use |
| 09/25/2008 | US20080233135 Cobalamin taxane bioconjugates |
| 09/25/2008 | US20080233132 Immunotherapy with myelin repair; immunoglobulins; autoimmune disorders |
| 09/25/2008 | US20080233127 Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitors |
| 09/25/2008 | US20080233126 G Proteins, Polynucleotides Encoding the Same and Utilization Thereof |
| 09/25/2008 | US20080233122 Complementarity determining regions; immunoglobulins; cell line, host cells; transgenic animals, plants |
| 09/25/2008 | US20080233121 Therapeutic treatments based on administration of small RNA fragments |
| 09/25/2008 | US20080233119 Modulating death receptor 3 and/or CD30 function; interleukin expression inhibition |
| 09/25/2008 | US20080233117 Reducing tumor growth |
| 09/25/2008 | US20080233116 Human monoclonal antibodies to CTLA-4 |
| 09/25/2008 | US20080233107 Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally sensitive transmembrane peptide |
| 09/25/2008 | US20080233106 Markers for labour |
| 09/25/2008 | US20080233104 Probiotic, lactic acid-producing bacteria and uses thereof |
| 09/25/2008 | US20080233102 administering a transglutaminase inhibitor, particularly a compound with a 3-halo-dihydroisoxazole moiety or an analog of isatin, to attenuate gluten toxicity |
| 09/25/2008 | US20080233099 Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels |
| 09/25/2008 | US20080233097 different phosphorylation site is the threonine residue in position 123 (Thr123) of mouse or human p38, alpha isoform; diagnostic marker of pathologies mediated by MAPKs |
| 09/25/2008 | US20080233096 transaminase, dehydrogenase, decarboxylase, ligase as glutamate modifying enzymes and oxaloacetate, pyruvate, NAD+, NADP+, 2-oxohexanedioic acid, 2-oxo-3-sulfopropionate, 2-oxo-3-sulfinopropionic acid, 2-oxo-3-phenylpropionic acid co-factors to enhance brain to blood efflux |
| 09/25/2008 | US20080233092 a lactose reduced dairy product such as fluid milk, a smoothie, a liquado, ice cream, yogurt or yogurt drink and an effective amount of a probiotic lactobacillus, bifidobacteria and carbohydrate polymer as prebiotics |
| 09/25/2008 | US20080233090 Method of Treatment by Administration of Rna |
| 09/25/2008 | US20080233086 Expression Vectors for Treating Bacterial Infections |
| 09/25/2008 | US20080233085 Use of Il-18Bp Isoforms for the Treatment and/or Prevention of Neurological Inflammatory Diseases |
| 09/25/2008 | US20080233083 Methods and Compositions for Vaccination of Animals with Prrsv Antigens with Improved Immunogenicity |
| 09/25/2008 | US20080233079 Crosslinked amine polymers |
| 09/25/2008 | US20080233078 Therapeutic polyesters and polyamides |
| 09/25/2008 | US20080233076 Process for stabilizing ascorbic acid compositions |
| 09/25/2008 | US20080233074 Composition and Method For Dry Cow Udder Protection |
| 09/25/2008 | US20080233073 Administering potassium binding polymer of alpha-fluoroacrylic acid comprising counterion of calcium crosslinked with divinylbenzene, (m)ethylenebisacrylamide, N,N'-bis(vinylsulfonylacetyl) ethylene diamine, 1,3-bis(vinylsulfonyl) 2-propanol, vinylsulfone, polyvinyl ether, polyallylether; hyperkalemia |
| 09/25/2008 | US20080233059 Heating and reacting polyglycerol with ricinoleic acid or another hydroxyl fatty acid to polymerize; maintaining temperature until reaction mixture reaches a desired acid value; esterification, condensation polymerization, catalysis with acid or basic catalyst; cosmetics, sunscreen agents, dairy products |
| 09/25/2008 | US20080233051 Organically modified silica nanoparticle incorporate two-photon absorption dye 9,10-Bis[4'-styryl-styryl]anthracenes and photosensizer 2-devinyl-2-(1-hexyloxyethyl)pyropheophorbide activated by fluorescence resonance energy transfer; displays unique aggregation induced fluorescence enhancement behavior |
| 09/25/2008 | US20080233047 Symmetric and Asymmetric Halogen-Containing Metallocarboranylporphyrins and Uses Thereof |
| 09/25/2008 | US20080233046 Antisense agents; RNA interference; gene expression inhibition; hybridomas; hormone replacement therapy |
| 09/25/2008 | US20080230058 Dry powder dispersing apparatus and methods for their use |
| 09/25/2008 | US20080230053 Aerosol drug delivery; nozzle; exterior gas supplying tube; interior microchannels with concentric configuration |
| 09/25/2008 | DE59410246C5 Pharmazeutische formulierung zur prophylaxe bzw. vorbehandlung einer vergiftung durch phosphororganische cholinesterasehemmer Pharmaceutical formulation for the prophylaxis or pre-treatment of poisoning by organophosphorus cholinesterase inhibitors |
| 09/25/2008 | DE10222588B4 Biomimetische Systeme aus Lipidmembranen gebunden an ein Substrat Biomimetic systems of lipid membranes bound to a substrate |
| 09/25/2008 | DE102007015701A1 Neue pharmazeutische Zusammensetzungen für die Lipolyse und Verfahren zu deren Herstellung Novel pharmaceutical compositions for the lipolysis and processes for their preparation |
| 09/25/2008 | DE102007014947A1 Stabilisierte wässrige Lösungen von Ergolinverbindungen The stabilized aqueous solutions of ergoline compounds |
| 09/25/2008 | DE102007014286A1 Fluorsubstituierte Amphetamine und Amphetaminderivate und deren Verwendung Fluorine-substituted amphetamines and amphetamine derivatives and their use |
| 09/25/2008 | DE102007013857A1 Neue Zusammensetzungen, insbesondere für die topische Behandlung von Hauterkrankungen New compositions, particularly for topical treatment of skin diseases |
| 09/25/2008 | DE102007013856A1 Substituierte Tetrahydropyrrolochinoline Substituted Tetrahydropyrrolochinoline |
| 09/25/2008 | DE102007013855A1 Substituierte Tetrahydrochinoline Substituted tetrahydroquinolines |
| 09/25/2008 | DE102007013854A1 Tetrahydrochinoline Tetrahydroquinolines |
| 09/25/2008 | DE102007013812A1 New 1-azacycloalkylimidazole derivatives useful for treating cancer, malaria, cardiovascular diseases or Alzheimer's disease |
| 09/25/2008 | DE102007013765A1 Lejimalid Analoga und Verwendung davon Lejimalid analogues and use thereof |
| 09/25/2008 | DE102005060690B4 Salze von Clopidogrel mit Polyanionen und ihre Verwendung zur Herstellung pharmazeutischer Formulierungen Salts of clopidogrel with polyanions and their use for the preparation of pharmaceutical formulations |
| 09/25/2008 | CA2685031A1 Composition for treating diabetes and metabolic disorders with quercetin, myrcetin and chlorogenic acid |
| 09/25/2008 | CA2684985A1 Combination of a narcotic and a non-narcotic analgesic |
| 09/25/2008 | CA2684592A1 Liquid formulations of salts of 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine |
| 09/25/2008 | CA2684321A1 Compositions comprising pkac fragments and uses thereof for inhibiting akt1, p70s6k or abl activity |
| 09/25/2008 | CA2682259A1 Compound that is a dual inhibitor of enzymes pde7 and/or pde4, pharmaceutical compositions and uses thereof |
| 09/25/2008 | CA2682195A1 Aminopyrimidines useful as kinase inhibitors |